Axa Investment Managers was among the participants in a $13.9m round for Alydia, which is developing a system to treat postpartum haemorrhage.
Axa Investment Managers, a division of insurance firm Axa, has led a $13.9m series C round for US-based obstetrics device developer Alydia Health through its Impact Investing Strategy vehicle.
The round included social impact investment fund Global Health Investment Fund (GHIF) and venture capital firm Avestria Ventures. It followed $10m in series B funding from GHIF, Astia Angels and unnamed additional investors in September 2018.
Alydia has built a medical device called Jada System to treat postpartum haemorrhage, a potentially…
